About Carboxypeptidase Q
Carboxypeptidase Q (CPQ) is a protein
from Homo sapiens identified by UniProt accession
Q9Y646, 472 residues long.
MolForge cross-references it against 0 known binders and
204 disease associations.
Target properties
| Protein name | Carboxypeptidase Q |
| UniProt accession | Q9Y646 |
| Gene | CPQ |
| Organism | Homo sapiens |
| Length | 472 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (204)
Diseases linked to this target (Open Targets).
- blood protein measurement · score 0.41
- age at first sexual intercourse measurement · score 0.37
- Abdominal pain · score 0.31
- Headache · score 0.31
- Limb pain · score 0.31
- appendicular lean mass · score 0.10
- Abnormality of refraction · score 0.10
- glioblastoma multiforme · score 0.08
- migraine disorder · score 0.06
- hemoglobin D disease · score 0.05
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q9Y646-F1 | alphafold | PREDICTED | 93.69 | — |
Amino-acid sequence (472 residues)
MKFLIFAFFG GVHLLSLCSG KAICKNGISK RTFEEIKEEI ASCGDVAKAI INLAVYGKAQ NRSYERLALL VDTVGPRLSG SKNLEKAIQI MYQNLQQDGL EKVHLEPVRI PHWERGEESA VMLEPRIHKI AILGLGSSIG TPPEGITAEV LVVTSFDELQ RRASEARGKI VVYNQPYINY SRTVQYRTQG AVEAAKVGAL ASLIRSVASF SIYSPHTGIQ EYQDGVPKIP TACITVEDAE MMSRMASHGI KIVIQLKMGA KTYPDTDSFN TVAEITGSKY PEQVVLVSGH LDSWDVGQGA MDDGGGAFIS WEALSLIKDL GLRPKRTLRL VLWTAEEQGG VGAFQYYQLH KVNISNYSLV MESDAGTFLP TGLQFTGSEK ARAIMEEVMS LLQPLNITQV LSHGEGTDIN FWIQAGVPGA SLLDDLYKYF FFHHSHGDTM TVMDPKQMNV AAAVWAVVSY VVADMEEMLP RS
Explore Carboxypeptidase Q with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets